Not applicableStudy completedNCT06703970What this trial is testingPlatelet Rich Plasma Versus Corticosteroids in Knee Osteoarthritis PainWho this might be right forKnee Osteoarthritis (OA) LifeBridge Health 52
Large-scale testing (Phase 3)Study completedNCT01539083What this trial is testingVelcade (Bortezomib) Consolidation After TransplantWho this might be right forMultiple Myeloma Janssen Scientific Affairs, LLC 256
Early research (Phase 1)Study completedNCT05925829What this trial is testingStromal Vascular Fraction and Autologous Activated Platelet-Rich Plasma Combination in Treating Treatment of Type 2 DiabetesWho this might be right forDiabetes Mellitus, Type 2Platelet-rich PlasmaStromal Vascular Fraction Hayandra Peduli Foundation 39
Large-scale testing (Phase 3)Active Not RecruitingNCT00572169What this trial is testingUARK 2006-66, Total Therapy 3B: An Extension of UARK 2003-33 Total TherapyWho this might be right forMultiple Myeloma University of Arkansas 177
Testing effectiveness (Phase 2)Study completedNCT06002854What this trial is testingComparison Of Outcome Of Microneedling With Autologous PRP Vs Microneedling With Topical Insulin In Treatment Of Post Acne Atrophic Scars.Who this might be right forATROPHIC ACNE SCARS Jinnah Postgraduate Medical Centre 50
Large-scale testing (Phase 3)Study completedNCT02541383What this trial is testingEvaluate Daratumumab in Transplant Eligible Participants With Previously Untreated Multiple MyelomaWho this might be right forMultiple Myeloma Intergroupe Francophone du Myelome 1,085
Very early researchUnknownNCT04156269What this trial is testingBCMA-CS1 Compound CAR (cCAR) T Cells for Relapsed/Refractory Multiple MyelomaWho this might be right forMultiple Myeloma iCell Gene Therapeutics 12
Early research (Phase 1)UnknownNCT05438394What this trial is testingClinical Study of Safety and Tolerability of Melphalan Hydrochloride for R/R MMWho this might be right forMultiple Myeloma Peking University People's Hospital 24
Not applicableStudy completedNCT04309942What this trial is testingEvaluation Study on Performance of Guided Clinical Pharmacy Consultation in Patients With Multiple Myeloma on First Oral Anticancer TreatmentWho this might be right forMultiple Myeloma Centre Hospitalier Universitaire de Nīmes 60
Testing effectiveness (Phase 2)Study completedNCT00006379What this trial is testingNon-Ablative Allo HSCT For Hematologic Malignancies or SAAWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+5 more Case Comprehensive Cancer Center 58
Testing effectiveness (Phase 2)Looking for participantsNCT05372354What this trial is testingEvaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple MyelomaWho this might be right forMultiple Myeloma Bristol-Myers Squibb 260
Testing effectiveness (Phase 2)Ended earlyNCT02353572What this trial is testingMelphalan and Bortezomib Prior to Autologous Stem Cell Transplant in Treating Patients With Multiple MyelomaWho this might be right forPlasma Cell MyelomaPlasmacytosisRecurrent Plasma Cell Myeloma+1 more University of Colorado, Denver 3
Testing effectiveness (Phase 2)Study completedNCT00000912What this trial is testingA Study on Amprenavir in Combination With Other Anti-HIV Drugs in HIV-Positive PatientsWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 475
Early research (Phase 1)Looking for participantsNCT05610865What this trial is testingEfficacy of Adipose Tissue Derived Stem Cells for the Treatment of Diabetic Foot UlcersWho this might be right forDiabetic Foot UlcerDiabetes MellitusDiabetic Foot+8 more University of the Punjab 28
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439357What this trial is testingTesting Trametinib as a Potential Targeted Treatment in Cancers With GNAQ or GNA11 Genetic Changes (MATCH-Subprotocol S2)Who this might be right forAdvanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more National Cancer Institute (NCI) 4
Not applicableWithdrawnNCT00770419What this trial is testingPerceptions of Burden in Patients With Late-Stage Cancer and Their CaregiversWho this might be right forBrain and Central Nervous System TumorsChronic Myeloproliferative DisordersDepression+7 more Rutgers, The State University of New Jersey
Testing effectiveness (Phase 2)Study completedNCT01217957What this trial is testingIxazomib Administered in Combination With Lenalidomide and Low-Dose Dexamethasone in Patients With Newly Diagnosed Multiple MyelomaWho this might be right forMultiple Myeloma Millennium Pharmaceuticals, Inc. 65
Post-approval studies (Phase 4)Ended earlyNCT02920177What this trial is testingPlatelet-rich Plasma Versus Corticosteroid Injection for the Treatment of Femoroacetabular ImpingementWho this might be right forFemoroacetabular Impingement University of Michigan 4
Not applicableEnded earlyNCT00726830What this trial is testingMethadone, Morphine, or Oxycodone in Treating Pain in Patients With CancerWho this might be right forBrain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more M.D. Anderson Cancer Center 1
Testing effectiveness (Phase 2)Looking for participantsNCT05909059What this trial is testingCAR T-cell Therapy in Patients With Renal DysfunctionWho this might be right forNon-hodgkin Lymphoma,B CellMultiple MyelomaAcute Lymphoblastic Leukemia, Adult Northside Hospital, Inc. 20